Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Statistical approaches for component-wise censored composite endpoints

Clinical Trials(2024)10.1177/17407745241265628Source: DataRank Database

Statistical approaches for component-wise censored composite endpoints is a research paper published in Clinical Trials (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.49)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Anne Eaton ORCID

Live enrichment

PubMed:39115164 PMC:PMC11533687 OpenAlex:https://openalex.org/W4401426184

national cancer institute

Grant: P30 CA77598

NCI NIH HHS

Grant: P30 CA077598

FWCI

0.49

Citation Percentile

0.7%

Citation Trend

2025

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11533687/pdf/nihms-2003185.pdf

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/17407745241265628

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/17407745241265628

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11533687

Fields of Study

Advanced Causal Inference TechniquesStatistical Methods in Clinical TrialsStatistical Methods and InferenceHumansEndpoint DeterminationHIV InfectionsRandomized Controlled Trials as TopicBreast FeedingData Interpretation, StatisticalInfantResearch DesignFemaleModels, StatisticalProportional Hazards ModelsInfant FormulaBias

MeSH Terms

Breast FeedingData Interpretation, StatisticalFemaleHumansInfantResearch DesignModels, StatisticalHIV InfectionsBiasProportional Hazards ModelsRandomized Controlled Trials as TopicEndpoint DeterminationInfant Formula

Keywords

Censoring (clinical trials)Survival analysisHazard ratioStatisticsEvent (particle physics)Confidence intervalProportional hazards modelTime pointMedicineEconometricsMathematicsCensoringProgression-free SurvivalComposite EndpointsTime-to-event

Sustainable Development Goals

SDG 0: Good health and well-being